Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.
Levati L, Bassi C, Mastroeni S, Lupini L, Antonini Cappellini GC, Bonmassar L, Alvino E, Caporali S, Lacal PM, Narducci MG, Molineris I, De Galitiis F, Negrini M, Russo G, D'Atri S. Levati L, et al. Among authors: negrini m. Cancers (Basel). 2022 Jul 29;14(15):3706. doi: 10.3390/cancers14153706. Cancers (Basel). 2022. PMID: 35954369 Free PMC article.
Oncogenic role of miR-483-3p at the IGF2/483 locus.
Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F, Zanesi N, Alder H, D'Elia G, Gramantieri L, Bolondi L, Lanza G, Querzoli P, Angioni A, Croce CM, Negrini M. Veronese A, et al. Among authors: negrini m. Cancer Res. 2010 Apr 15;70(8):3140-9. doi: 10.1158/0008-5472.CAN-09-4456. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388800 Free PMC article.
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.
Ferracin M, Zagatti B, Rizzotto L, Cavazzini F, Veronese A, Ciccone M, Saccenti E, Lupini L, Grilli A, De Angeli C, Negrini M, Cuneo A. Ferracin M, et al. Among authors: negrini m. Mol Cancer. 2010 May 26;9:123. doi: 10.1186/1476-4598-9-123. Mol Cancer. 2010. PMID: 20504344 Free PMC article. Clinical Trial.
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome.
Narducci MG, Arcelli D, Picchio MC, Lazzeri C, Pagani E, Sampogna F, Scala E, Fadda P, Cristofoletti C, Facchiano A, Frontani M, Monopoli A, Ferracin M, Negrini M, Lombardo GA, Caprini E, Russo G. Narducci MG, et al. Among authors: negrini m. Cell Death Dis. 2011 Apr 28;2(4):e151. doi: 10.1038/cddis.2011.32. Cell Death Dis. 2011. PMID: 21525938 Free PMC article.
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.
Callegari E, Elamin BK, Giannone F, Milazzo M, Altavilla G, Fornari F, Giacomelli L, D'Abundo L, Ferracin M, Bassi C, Zagatti B, Corrà F, Miotto E, Lupini L, Bolondi L, Gramantieri L, Croce CM, Sabbioni S, Negrini M. Callegari E, et al. Among authors: negrini m. Hepatology. 2012 Sep;56(3):1025-33. doi: 10.1002/hep.25747. Epub 2012 Jul 13. Hepatology. 2012. PMID: 22473819
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs.
Lupini L, Bassi C, Ferracin M, Bartonicek N, D'Abundo L, Zagatti B, Callegari E, Musa G, Moshiri F, Gramantieri L, Corrales FJ, Enright AJ, Sabbioni S, Negrini M. Lupini L, et al. Among authors: negrini m. Front Genet. 2013 Apr 25;4:64. doi: 10.3389/fgene.2013.00064. eCollection 2013. Front Genet. 2013. PMID: 23630541 Free PMC article.
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.
Rigolin GM, Saccenti E, Rizzotto L, Ferracin M, Martinelli S, Formigaro L, Cibien F, Cavallari M, Lista E, Daghia G, Sofritti O, Ciccone M, Cavazzini F, Lupini L, Bassi C, Zagatti B, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: negrini m. Oncotarget. 2014 Jan 15;5(1):140-9. doi: 10.18632/oncotarget.1382. Oncotarget. 2014. PMID: 24334759 Free PMC article.
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, Ferracin M, D'Abundo L, Saccenti E, Matis S, Lionetti M, Agnelli L, Gentile M, Recchia AG, Bossio S, Reverberi D, Rigolin G, Calin GA, Sabbioni S, Russo G, Tassone P, Morabito F, Ferrarini M, Neri A. Negrini M, et al. Clin Cancer Res. 2014 Aug 1;20(15):4141-53. doi: 10.1158/1078-0432.CCR-13-2497. Epub 2014 Jun 10. Clin Cancer Res. 2014. PMID: 24916701
738 results